Recent Progress in Oculopharyngeal Muscular Dystrophy

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, progressive myopathy.
• It stems from abnormal trinucleotide repeat expansion in the *PABPN1* gene.
• Symptoms include ptosis, dysphagia, and limb weakness, with variable progression.

Purpose of the Study:

• To review recent clinical and pathological findings in OPMD.
• To propose establishing a nationwide OPMD patient registry in Japan.
• To address unmet medical needs and identify therapeutic targets.

Main Methods:

• Literature review of OPMD clinical and pathological studies.
• Proposal for a nationwide patient registry in Japan.

Main Results:

• OPMD is caused by (GCN)n repeat expansion in the *PABPN1* gene.
• Autologous myoblast transplantation shows potential therapeutic benefits.
• Patient data is essential for treatment development in non-endemic areas.

Conclusions:

• A Japanese OPMD patient registry is vital for understanding disease burden.
• The registry will facilitate identification of therapeutic targets and efficacy measures.
• This initiative aims to improve treatment strategies for OPMD patients.